• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高临床试验报告的透明度。

Improving transparency in clinical trial reporting.

作者信息

Farrell Alison

机构信息

Public Library of Science, San Francisco, California, United States of America.

出版信息

PLoS Med. 2025 Apr 28;22(4):e1004588. doi: 10.1371/journal.pmed.1004588. eCollection 2025 Apr.

DOI:10.1371/journal.pmed.1004588
PMID:40294530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12037211/
Abstract

The power to interpret the results of randomised clinical trial results relies on transparent reporting of the study design, protocol, methods and analyses. Without such clarity, the benefits of the findings, to both healthcare, policy and research, cannot be realized in full. The publication of the updated CONSORT 2025 and SPIRIT 2025 statements for reporting of randomised clinical trials and protocols, respectively, offers the opportunity to reflect on the power that transparent reporting of clinical trial design and data offers to improve the quality of trials and outcomes.

摘要

解读随机临床试验结果的能力取决于对研究设计、方案、方法和分析的透明报告。没有这种清晰度,研究结果在医疗保健、政策和研究方面的益处就无法充分实现。分别用于报告随机临床试验和方案的更新后的CONSORT 2025和SPIRIT 2025声明的发布,为反思临床试验设计和数据的透明报告对提高试验质量和结果的作用提供了契机。

相似文献

1
Improving transparency in clinical trial reporting.提高临床试验报告的透明度。
PLoS Med. 2025 Apr 28;22(4):e1004588. doi: 10.1371/journal.pmed.1004588. eCollection 2025 Apr.
2
Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.儿科临床试验方案和报告中报告项目的建议与证据:两项系统评价
Trials. 2015 Sep 18;16:417. doi: 10.1186/s13063-015-0954-0.
3
Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).改善临床试验报告和方案中的结果报告:临床试验计划终点报告工具(InsPECT)的研究方案。
Trials. 2019 Mar 6;20(1):161. doi: 10.1186/s13063-019-3248-0.
4
Mixed-methods study to develop extensions to the SPIRIT and CONSORT statements for factorial randomised trials: the Reporting Factorial Trials (RAFT) study.一项混合方法研究,旨在为析因随机试验开发SPIRIT和CONSORT声明的扩展内容:析因试验报告(RAFT)研究。
BMJ Open. 2025 Feb 17;15(2):e082917. doi: 10.1136/bmjopen-2023-082917.
5
SPIRIT 2025 statement: updated guideline for protocols of randomised trials.《SPIRIT 2025声明:随机试验方案的更新指南》
BMJ. 2025 Apr 28;389:e081477. doi: 10.1136/bmj-2024-081477.
6
Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.用于制定《SPIRIT 2024声明》和《CONSORT 2024声明》的方法。
J Clin Epidemiol. 2024 May;169:111309. doi: 10.1016/j.jclinepi.2024.111309. Epub 2024 Feb 29.
7
SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.《SPIRIT 2025声明:随机试验方案的更新指南》
PLoS Med. 2025 Apr 28;22(4):e1004589. doi: 10.1371/journal.pmed.1004589. eCollection 2025 Apr.
8
CONSORT 2010 statement: extension checklist for reporting within person randomised trials.CONSORT 2010 声明:报告个体随机试验内的扩展清单。
Br J Dermatol. 2019 Mar;180(3):534-552. doi: 10.1111/bjd.17239. Epub 2019 Jan 4.
9
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.适应性设计 CONSORT 扩展(ACE)声明:一份带有解释和说明指南的清单,用于报告使用适应性设计的随机试验。
Trials. 2020 Jun 17;21(1):528. doi: 10.1186/s13063-020-04334-x.
10
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.适应性设计 CONSORT 扩展(ACE)声明:一份带有解释和说明指南的清单,用于报告使用适应性设计的随机试验。
BMJ. 2020 Jun 17;369:m115. doi: 10.1136/bmj.m115.

引用本文的文献

1
Charting the future of PLOS Medicine: Priorities for evidence, impact, and equity.绘制《公共科学图书馆·医学》的未来蓝图:证据、影响力与公平性的优先事项
PLoS Med. 2025 Jul 30;22(7):e1004691. doi: 10.1371/journal.pmed.1004691. eCollection 2025 Jul.

本文引用的文献

1
SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.《SPIRIT 2025声明:随机试验方案的更新指南》
PLoS Med. 2025 Apr 28;22(4):e1004589. doi: 10.1371/journal.pmed.1004589. eCollection 2025 Apr.
2
CONSORT 2025 statement: Updated guideline for reporting randomised trials.CONSORT 2025声明:报告随机试验的更新指南。
PLoS Med. 2025 Apr 14;22(4):e1004587. doi: 10.1371/journal.pmed.1004587. eCollection 2025 Apr.
3
Embedding Patient and Health Care Professional Voices in Clinical Trials.在临床试验中纳入患者和医疗保健专业人员的意见。
JAMA. 2024 Aug 6;332(5):365-366. doi: 10.1001/jama.2024.6314.
4
Assessment of transparency indicators across the biomedical literature: How open is open?评估生物医学文献中的透明度指标:开放有多开放?
PLoS Biol. 2021 Mar 1;19(3):e3001107. doi: 10.1371/journal.pbio.3001107. eCollection 2021 Mar.